Core Viewpoint - The Bio-based 2026 Exhibition aims to provide a professional platform for showcasing and exchanging innovative products in the bio-based industry, promoting industry development and international collaboration [2][3]. Exhibition Overview - The Bio-based 2026 Exhibition will take place from May 20-22, 2026, at the Shanghai Fuyue Hotel, featuring over 60 exhibitors and more than 1000 new product displays, with an expected attendance of over 1500 participants [2][3]. - The exhibition will include various activities such as a special session for brand demand matching, a standard review meeting for bio-based materials, new product and technology release events, and a high-level strategic seminar [3][12]. Audience Profile - The expected audience for the Bio-based 2026 Exhibition includes over 1500 participants from the entire bio-based product supply chain, including senior executives, decision-makers, R&D personnel, and end-user material managers [6][12]. - The audience composition is diverse, with 30% from bio-based chemical/material companies, 20% from research institutions, and 17% from user/product units, among others [12]. Industry Transformation Demand - The exhibition has attracted over 1000 downstream and end-brand companies focusing on transitioning to low-carbon and green materials, covering sectors such as packaging, consumer goods, sportswear, automotive, fashion, beauty, and health [13]. - A key function of the Bio-based Exhibition is to identify downstream brand needs and facilitate precise industry connections to promote sustainable development across the industry [13].

Core Insights - The biomanufacturing industry in China has grown significantly, with a total scale reaching 1.1 trillion yuan, and bioproducts accounting for over 70% of global production [1] - The industry is expected to be a core driver of the Fourth Industrial Revolution, emphasizing the importance of biomanufacturing in fostering new productive forces and advancing new industrialization [1] - The "14th Five-Year Plan" period is projected to see continued growth in biobased materials and chemicals, with bioproduct output increasing by approximately 20% compared to the end of the "13th Five-Year Plan" [1] Industry Growth and Innovation - Significant breakthroughs in technology and product innovation have been achieved, including high-throughput gene sequencers and AI protein design platforms, leading to the commercialization of various biomanufactured products [2] - The emergence of biomanufacturing clusters, such as in Shenzhen and Hainan, showcases localized development and the establishment of significant production capabilities in amino acids and marine biomanufacturing [2] - The Ministry of Industry and Information Technology has announced key lists related to high-performance bioreactor innovation and pilot capabilities, indicating a structured approach to industry advancement [3] Future Development Plans - The "15th Five-Year Plan" will focus on enhancing the biomanufacturing ecosystem, including the establishment of pilot platforms and the cultivation of composite talents in the sector [3] - Emphasis will be placed on addressing fundamental scientific issues and engineering bottlenecks in biomanufacturing, promoting deep integration of technological and industrial innovation [3] - The industry aims to expand applications in future food and healthcare sectors, leveraging advancements in biomanufacturing technologies [3] Recommendations for High-Quality Development - The establishment of a comprehensive innovation system, modern industrial system, and management service system is recommended to accelerate high-quality development in biomanufacturing [4] - Support for diverse development routes and the creation of significant biomanufactured products is essential, alongside the establishment of regional innovation platforms [4] - Financial services tailored to biomanufacturing enterprises should be developed to support market-oriented operations and the growth of specialized small and medium enterprises [5]